ConductScience.org, home

Paper3368191

Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity?

Ogita S and 3 others. Oncology, 1988. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity? Papers, record 3368191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3368191

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity?
PubMed
Journal
Oncology
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2018-02-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ogita SS
2Tokiwa KK
3Arizono NN
4Takahashi TT

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
NeuroblastomaMajor topic
Alprostadil
Cell Differentiation
Humans
Papaverine

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
40448172SLIT3-mediated intratumoral crosstalk induces neuroblastoma differentiation via a spontaneous regression-like program.J Transl Med2025https://conductscience.org/library/papers/40448172PubMed
24255631Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.Korean J Pathol2013https://conductscience.org/library/papers/24255631PubMed
23483759Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.Ann Lab Med2013https://conductscience.org/library/papers/23483759PubMed
23314735p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.Cancer Chemother Pharmacol2013https://conductscience.org/library/papers/23314735PubMed
20596986Chemotherapy-induced neuronal maturation in sinonasal teratocarcinosarcoma--a unique observation.Head Neck Pathol2009https://conductscience.org/library/papers/20596986PubMed
18528516PPARgamma in Neuroblastoma.PPAR Res2008https://conductscience.org/library/papers/18528516PubMed
2573830Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Mol Cell Biol1989https://conductscience.org/library/papers/2573830PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3368191

GET https://conductscience.org/api/papers/v1/3368191/authors